These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The assessment of drugs in obsessional states. Philpott R Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):91-5. PubMed ID: 973952 [No Abstract] [Full Text] [Related]
25. Obsessive-compulsive disorder in elderly patients. Jackson CW Drugs Aging; 1995 Dec; 7(6):438-48. PubMed ID: 8601051 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of clomipramine in obsessive-compulsive disorder. Howland RH Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602 [No Abstract] [Full Text] [Related]
27. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study. Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048 [TBL] [Abstract][Full Text] [Related]
28. Adults with early-onset obsessive-compulsive disorder. Rosario-Campos MC; Leckman JF; Mercadante MT; Shavitt RG; Prado HS; Sada P; Zamignani D; Miguel EC Am J Psychiatry; 2001 Nov; 158(11):1899-903. PubMed ID: 11691698 [TBL] [Abstract][Full Text] [Related]
29. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184 [TBL] [Abstract][Full Text] [Related]
31. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
32. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment. Marcourakis T; Bernik MA; Lotufo Neto F; Gedanke Shavitt R; Gorenstein C Int Clin Psychopharmacol; 2015 Jan; 30(1):43-8. PubMed ID: 25279584 [TBL] [Abstract][Full Text] [Related]
34. Pharmacologic management of obsessive-compulsive disorder. Jackson CW; Morton WA; Lydiard RB South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850 [TBL] [Abstract][Full Text] [Related]
35. Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia. Marazziti D; Carlini M; Dell'Osso L Curr Top Med Chem; 2012; 12(4):238-53. PubMed ID: 22204483 [TBL] [Abstract][Full Text] [Related]